Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 45, Issue -, Pages 73-81Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2017.01.003
Keywords
-
Categories
Funding
- Worldwide Cancer Research Grant [15-1146]
- Asociacion Espanola contra el Cancer AECC Foundation grant [GCB15152947MELE]
- Asociacion Espanola contra el Cancer Foundation
Ask authors/readers for more resources
Natural Killer (NK) cells are cytotoxic lymphocytes specialized in early defense against virus-infected and transformed cells. NK-cell function is regulated by activating and inhibitory surface receptors recognizing their ligands on transformed cells. Modulation of NK numbers and/ or function by a variety of agents such as cytokines and monoclonal antibodies may result in enhanced anti-tumor activity. Recombinant cytokines (i.e., IL-15 and IL-2), antibodies blocking inhibitory receptors (i.e., KIR, NKG2A and TIGIT) and agonists delivering signals via CD137, NKG2D and CD16 stand out as the most suitable opportunities. These agents can be used to potentiate NKcell-mediated antibody-dependent cellular cytotoxicity (ADCC) against antibody-coated tumor cells, offering potential for multiple combinatorial immunotherapy strategies against cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available